UK

The Nottingham site also supports Codis’ commercial spray-drying operations in Haverhill, U.K., where the company is increasing capacity by installing a new GEA Pharma-SD PSD-4 commercial spray dryer, with validation planned for 2027.

Following the sale, Clarivate will concentrate on its Academia & Government (A&G) and Intellectual Property (IP) divisions.

Founded in 2019 as a spinout from Imperial College London and the Francis Crick Institute, Myricx has attracted strong investor backing and has emerged as one of the UK’s leading oncology biotechnology companies.

The rollout follows the device’s receipt of both CE mark and UK Conformity Assessed (UKCA) certification, allowing hospitals and healthcare providers in eligible European countries to begin purchasing the system.

The move follows Sanner’s acquisition of Springboard in January 2024 and reflects the company’s goal of building a seamless, end-to-end CDMO platform spanning medical technology, pharmaceuticals, and biotechnology.

The Respiratory Summit 2026, held in London, brought together representatives from the asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, and chronic rhinosinusitis communities for the first time under a shared prevention agenda.

This broader licence gives AviadoBio the flexibility to explore new development pathways and external collaborations while continuing to advance its central nervous system pipeline.

The EMA Committee for Orphan Medicinal Products supported the designation after recognising a strong unmet need in neuroendocrine carcinomas.

Anaphylaxis occurs when the immune system overreacts to a substance it perceives as harmful, triggering symptoms that can rapidly become life-threatening.